Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
2 Biotech Stocks to Help Recession-Proof Your Portfolio
Tickers CRSP EXEL VRTX
Tags VRTX Recent Press Releases FBIOX
From Motley Fool
1 Reason to Buy Exelixis Stock, and 1 Reason to Sell
Tickers BMY EXEL
Tags BMY Recent Press Releases EXEL
From Motley Fool
7 Best Biotech Stocks to Buy in July 2022
Tickers AAPL ALPMY AMGN AZN
Tags HON MSFT BIIB
From InvestorPlace
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Tickers ADVM AVTX CLVS CTMX
Tags Market News Small Cap ADVM
From Benzinga
3 Beaten-Down Growth Stocks to Buy Now and Hold Forever
Tickers BMY EXEL TCNNF TDOC
Tags BMY Recent Press Releases EXEL
From Motley Fool
2 Biotech Stocks That Could Make You Richer
Tickers EXEL MRNA XBI
Tags XBI Recent Press Releases EXEL
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
Tickers ACB AGL AIZ AMP
Tags Downgrades CANO AMRS
From Benzinga
Stock Market Plunge: 5 Amazing Stocks You Won't Regret Buying
Tickers AEO DIS EXEL USB
Tags Recent Press Releases EXEL V
From Motley Fool
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Tickers ABBV ACER ARDX CLDX
Tags ABBV FDA Biotech
From Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Tickers ACIU ACLX ACOR AQST
Tags Small Cap Offerings Market News
From Benzinga
Exelixis-BioInvent Establish Immuno-Oncology Pact
Tickers BOVNF EXEL
Tags Contracts Benzinga General
From Benzinga
4 Supercharged Growth Stocks Billionaires Can't Stop Buying
Tickers EXEL SKLZ SQ TSLA
Tags Recent Press Releases EXEL TSLA
From Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on
Tickers ADT ALB AVLR BILL
Tags EXEL TTD ADT
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Tickers ACRX CYAD DAWN DRTS
Tags DRTS TNYA NURO
From Benzinga
Can This Cancer Stock Maintain Its Momentum?
Tickers EXEL
Tags Market News EXEL Recent Press Releases
From Motley Fool
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
Tickers BMY ETSY EXEL IPSEY
Tags ISRG IPSEY ETSY
From Motley Fool
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
Tickers EXEL
Tags Market News Recent Press Releases EXEL
From Motley Fool
Exelixis: Q1 Earnings Insights
Tickers EXEL
Tags Earnings Market News Benzinga
From Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags BMY OPNT IMTX
From Benzinga
3 Growth Stocks to Buy With $1,000 Right Now
Tickers BMY CURLF EXEL PINS
Tags CURLF PINS BMY
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags KOD Benzinga IPSEY
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags General News IPSEF
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
Tickers BCRX BNTX EXEL ITOS
Tags MRUS Market News BNTX
From InvestorPlace
Nasdaq Bear Market: 3 of the Safest Stocks to Buy on the Dip
Tickers AVGO BRK-A BRK-B EXEL
Tags Market News EXEL Recent Press Releases
From Motley Fool
3 No-Brainer Stocks to Buy With $1,000 During the Market Sell-Off
Tickers AVGO EXEL FB
Tags AVGO EXEL Recent Press Releases
From Motley Fool
2 Stocks Defying the Market Sell-Off Right Now
Tickers BMY EXEL
Tags BMY EXEL Recent Press Releases
From Motley Fool
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags Market News Biotech EXEL
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags ESALY Small Cap Market News
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags EXEL Liver Cancer RHHBY
From Benzinga
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
Tickers EXEL FIGS NVAX
Tags Market News FIGS NVAX
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.